Pictet Asset Management’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-684,892
Closed -$5.55M 2081
2024
Q3
$5.55M Sell
684,892
-193,763
-22% -$1.57M 0.01% 782
2024
Q2
$7.45M Sell
878,655
-1,164,956
-57% -$9.88M 0.01% 699
2024
Q1
$18.4M Sell
2,043,611
-124,786
-6% -$1.12M 0.02% 508
2023
Q4
$24.4M Buy
2,168,397
+160,144
+8% +$1.8M 0.03% 431
2023
Q3
$17.3M Buy
+2,008,253
New +$17.3M 0.02% 492